Jasper Therapeutics, Inc. (JSPR)

Import this data to Google Sheets with:

=jivedata("JSPR","financials")

Full statements spill as a table. For one cell: =jivedata("JSPR","Revenue") or =jivedata("JSPR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Jasper Therapeutics, Inc.

JSPR • CIK 0001788028

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cost of Revenue	—	—	$41,635	$23,313
Operating Expenses	$68,861	$76,239	$83,883	$55,164
Nonoperating Income (Expense)	—	$4,970	$8,082	$23,393
Net Income (Loss) Attributable to Parent	$-64,465	$-71,269	$-75,801	$-31,771
Restructuring Costs	—	—	$2,253	$2,253
Impairment of Long-Lived Assets to be Disposed of	—	—	$1,112	$1,112

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$86,887	$71,637	$28,692	$7,314
Prepaid Expense and Other Assets, Current	$2,051	$4,174	$5,953	$3,840
Property, Plant and Equipment, Net	$2,727	$1,875	$102	$60
Operating Lease, Right-of-Use Asset	$1,467	$976	$502	$128
Restricted Cash, Noncurrent	$417	$417	$417	$417
Other Assets, Noncurrent	$1,343	$820	$113	$43
Assets	$94,892	$79,899	$35,779	$11,802
Assets, Current	$88,938	$75,811	$34,645	$11,571
Accounts Payable, Current	$4,149	$4,027	$6,220	$2,778
Operating Lease, Liability, Current	$972	$1,089	$1,235	$270
Accounts Payable and Other Accrued Liabilities, Current	$7,253	$10,121	$5,745	$4,797
Operating Lease, Liability, Noncurrent	$1,814	$724	$724	$201
Warrants and Rights Outstanding	$150	—	$16,164	$2,544
Other Liabilities, Noncurrent	$2,264	$2,264	$2,264	$2,264
Common Stock, Value, Issued	$1	$2	$3	$3
Additional Paid in Capital	$248,039	$302,541	$320,818	$322,014
Retained Earnings (Accumulated Deficit)	$-169,600	$-240,869	$-316,670	$-320,604
Stockholders' Equity Attributable to Parent	$78,440	$61,674	$4,151	$1,413
Liabilities, Current	$12,374	$15,237	$13,200	$7,845
Liabilities	$16,452	$18,225	$31,628	$10,389
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Common Stock, Shares Authorized	492,000,000	492,000,000	492,000,000	492,000,000
Common Stock, Shares, Issued	11,163,896	15,022,122	27,996,819	28,079,552
Depreciation, Depletion and Amortization, Nonproduction	—	$1,373	$1,056	$42
Other Research and Development Expense	$2,300	—	$800	$800

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("JSPR","financials")

Full statements spill as a table. For one cell: =jivedata("JSPR","Revenue") or =jivedata("JSPR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.